WINNERS & LOSERS: Evoke agrees bid; Imaging Biometrics positive trials
(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Friday. Read More
| Price | 3.35p on 12-06-2026 at 08:36:53 |
|---|---|
| Change | -0.10p -2.9% |
| Buy | 3.50p |
| Sell | 3.20p |
| Last Trade: | Buy 66.00 at 3.50p |
| Day's Volume: | 16,276 |
| Last Close: | 3.45p |
| Open: | 3.45p |
| ISIN: | GB00BMFZVZ53 |
| Day's Range | 3.35p - 3.45p |
| 52wk Range: | 2.30p - 5.55p |
| Market Capitalisation: | £14.53m |
| VWAP: | 3.312241p |
| Shares in Issue: | 433.79m |
Sector: Fossil Fuels
Listed In: FTSE AIM All-Share,
Prospex Eng (PXEN) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 66 | 3.50p | SI Trade |
09:36:52 - 12-Jun-26 |
| Buy* | 31 | 3.50p | SI Trade |
09:36:52 - 12-Jun-26 |
| Sell* | 15,000 | 3.30p | Ordinary |
09:36:38 - 12-Jun-26 |
| Buy* | 27 | 3.50p | SI Trade |
09:00:34 - 12-Jun-26 |
| Buy* | 30 | 3.50p | SI Trade |
09:00:34 - 12-Jun-26 |
| Sell* | 156 | 3.30p | SI Trade |
09:00:34 - 12-Jun-26 |
| Sell* | 27 | 3.30p | SI Trade |
09:00:34 - 12-Jun-26 |
| Buy* | 28 | 3.50p | SI Trade |
09:00:34 - 12-Jun-26 |
| Buy* | 790 | 3.50p | SI Trade |
09:00:34 - 12-Jun-26 |
| Sell* | 121 | 3.34p | Ordinary |
08:07:26 - 12-Jun-26 |
Prospex Eng (PXEN) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 11th Jun 2026 7:00 am | RNS-R | AGM to be Broadcast via IMC |
| 5th Jun 2026 7:00 am | RNS | Director/PDMR Shareholding |
| 1st Jun 2026 7:00 am | RNS | Strategic Collaboration with IMMAGE |
| 28th May 2026 7:00 am | RNS | Final Results & Notice of AGM |
| 15th May 2026 7:00 am | RNS | Q1 2026 Overview &Unaudited Group Financial Update |
| 7th May 2026 7:00 am | RNS | Board Changes |
| 30th Apr 2026 7:00 am | RNS | Italy Selva Malvezzi - Q1 2026 Activity Report |
| 22nd Apr 2026 7:00 am | RNS | Dunajec Licence Award, Poland |
| 1st Apr 2026 7:00 am | RNS | San Licence Award, Poland |
| 26th Mar 2026 2:50 pm | RNS | Corporate Update & New Corporate Presentation |